Literature DB >> 7333328

Gas-chromatographic determination of levamisole in human plasma-normalization and reliability of the method.

F Rousseau, J M Haguenoer, D Lesieur, A P Gamot.   

Abstract

Levamisole has been used by many authors as an immunostimulant agent but the relationship between oral doses, plasma level and the therapeutic effects were not known. For such a study it was necessary to establish an accurate and reproducible method of measurement. We describe a modification of the gas chromatographic method of Wynants et al. (1975). The normalization of the extraction of the extraction process leads to greater reliability and accuracy (4 ng +/- 7.6%). Reproducibility was established using a series of 30 determinations from standard solutions and plasmas supplemented with Levamisole. The relative standard deviation in K evaluation was varied between 0.9 and 1.8%, 3.7 and 6.1% for standard solutions and plasmas respectively. Consequently this method was adopted for this pharmacokinetic study which was carried out on healthy and cancer patients.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7333328     DOI: 10.1007/BF03189527

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  1 in total

1.  [Immunostimulating effect of an imidotiiazole in the immunization of mice against Brucella abortus infection].

Authors:  G Renoux; M Renoux
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1971-01-11
  1 in total
  3 in total

Review 1.  Clinical pharmacokinetics of anthelmintic drugs.

Authors:  G Edwards; A M Breckenridge
Journal:  Clin Pharmacokinet       Date:  1988-08       Impact factor: 6.447

2.  Quantitation of levamisole in plasma using high performance liquid chromatography.

Authors:  T F Vandamme; M Demoustier; B Rollmann
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1995 Apr-Jun       Impact factor: 2.441

3.  Pharmacokinetics of levamisole in healthy subjects and cancer patients.

Authors:  M Luyckx; F Rousseau; M Cazin; C Brunet; J C Cazin; J M Haguenoer; B Devulder; I Lesieur; D Lesieur; P Gosselin; L Adenis; P Cappelaere; A Demaille
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1982 Oct-Dec       Impact factor: 2.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.